JNJ03.BK Johnson & Johnson

- THB
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
1.19%
Fundamental score
-

Is JNJ03.BK undervalued?

Graham number

The Graham number of Johnson & Johnson cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Johnson & Johnson fundamental analysis

No fundamental analysis for Johnson & Johnson yet.

Johnson & Johnson stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers,…

Full company profile